⌘K

Home/Insiders/Dudley Robert Michael

DR

SEC Insider//CIK 0001854161

Dudley Robert Michael

CIK 00018541611 companyBOSTON, MA

Transactions

11

Companies

1

Filings

9

CIK

0001854161

Recent Transactions

11 trades

Purchase
Transcode Therapeutics, Inc.$RNAZ
Common Stock
2023-09-28$0.51/sh+98,000→ 180,262 total
Purchase
Transcode Therapeutics, Inc.$RNAZ
Common Stock
2023-06-21$2.65/sh+12,000→ 82,262 total
Purchase
Transcode Therapeutics, Inc.$RNAZ
Common Stock
2023-06-20$2.55/sh+6,607→ 70,262 total
Purchase
Transcode Therapeutics, Inc.$RNAZ
Common Stock
2023-06-09$2.76/sh+19,000→ 61,155 total
Purchase
Transcode Therapeutics, Inc.$RNAZ
Common Stock
2023-06-09$2.76/sh+19,000→ 912,114 total
Award
Transcode Therapeutics, Inc.$RNAZ
Stock Option (right to buy)
2023-05-19+735,000→ 735,000 total
Award
Transcode Therapeutics, Inc.$RNAZ
Stock Option (Right to Buy)
2022-12-12+135,000→ 135,000 total
Purchase
Transcode Therapeutics, Inc.$RNAZ
Common Stock
2022-09-14$1.15/sh+20,000→ 893,114 total
Purchase
Transcode Therapeutics, Inc.$RNAZ
Common Stock
2022-05-31$1.87/sh+2,000→ 873,114 total
Purchase
Transcode Therapeutics, Inc.$RNAZ
Common Stock
2022-05-27$1.84/sh+28,000→ 871,114 total
Award
Transcode Therapeutics, Inc.$RNAZ
Stock Option (Right to Buy)
2022-02-01+135,000→ 135,000 total

Companies

1

Transcode Therapeutics, Inc.
Director, Chief Executive Officer, 10% Owner
$RNAZ

Recent Filings

9

Address

C/O TRANSCODE THERAPEUTICS, INC. 6 LIBERTY SQUARE, #2382

BOSTON, MA, 02109

View on SEC.gov